Ompekimig
Ompekimig is a humanized immunoglobulin monoclonal antibody targeting human interleukin 4 (IL-4) and interleukin 13 (IL-13) . Ompekimig is promising for research of immune-mediated inflammatory diseases, such as asthma and atopic dermatitis[1].
Product Specifications
CAS Number
[2981477-39-6]
UNSPSC
12352203
Target
Interleukin Related
Related Pathways
Immunology/Inflammation
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
References & Citations
[1]World Health Organization. WHO Drug Information: Volume 38[M]. World Health Organization, 2024.
Shipping Conditions
Room temperature
Scientific Category
Inhibitory Antibodies
Clinical Information
No Development Reported
Isoform
IL-13; IL-4
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
